Mandate

Vinge advises the sellers in the sale of Larodan AB to ABITEC Corporation

Vinge advises the owners of Larodan AB in the sale of the company to ABITEC Corporation, a subsidiary in the listed corporate group Associated British Foods, plc (“ABF”).

Larodan AB develops, manufactures and sells a broad range of high purity lipids for research and analytical purposes to customers across the world. The transaction is of strategic importance for ABITEC and ABF, as it expands the group’s product portfolio and provides ABITEC with an R&D site in Europe.

The Vinge team consisted primarily of Jesper Ottergren, Victoria Johnsson Grossman and Charlotte Akej (M&A) and Daniel Melander Björner (Employment Law).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025